Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

X4 Pharmaceuticals (XFOR) Other Gross PP&E Adjustments (2018 - 2025)

X4 Pharmaceuticals' Other Gross PP&E Adjustments history spans 8 years, with the latest figure at $5000.0 for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments rose 100.36% year-over-year to $5000.0; the TTM value through Dec 2025 reached $5000.0, up 100.36%, while the annual FY2025 figure was $5000.0, 100.36% up from the prior year.
  • Other Gross PP&E Adjustments reached $5000.0 in Q4 2025 per XFOR's latest filing, up from -$1.8 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $5000.0 in Q4 2025 to a low of -$7.6 million in Q1 2021.
  • Average Other Gross PP&E Adjustments over 5 years is -$4.0 million, with a median of -$3.9 million recorded in 2023.
  • Peak YoY movement for Other Gross PP&E Adjustments: crashed 737.34% in 2021, then soared 100.36% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$6.5 million in 2021, then grew by 24.34% to -$4.9 million in 2022, then surged by 32.9% to -$3.3 million in 2023, then skyrocketed by 57.82% to -$1.4 million in 2024, then soared by 100.36% to $5000.0 in 2025.
  • Per Business Quant, the three most recent readings for XFOR's Other Gross PP&E Adjustments are $5000.0 (Q4 2025), -$1.8 million (Q3 2025), and -$1.2 million (Q2 2025).